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Overall, the results obtained in both the U.S. and the Russian space programs indicate that most space crews will 
experience some symptoms of motion sickness (MS) causing significant impact on the operational objectives that 
must be accomplished to assure mission success. At this time the primary countermeasure for MS requires the 
administration of Promethazine. Promethazine is not a benign drug, and is most frequently administered just prior to 
the sleep cycle to prevent its side effects from further compromising mission objectives. Clearly other 
countermeasures for SMS must be developed. Currently the primary focus is on two different technologies: (1) 
developing new and different pharmacological compounds with less significant side effects, (2) preflight training. 
The primary problem with all of these methods for controlling MS is time. New drugs that may be beneficial are 
years from testing and development, and preflight training requires a significant investment of crew time during an 
already intensive pre-launch schedule. Granted, motion sickness symptoms can be minimized with either of the two 
methods detailed above, however, it may be possible to develop a countermeasure that does not require either 
extensive adaptation time or exposure to motion sickness. 
Approximately 25 years ago Professor Geoffrey Melvill Jones presented his work on adaptation of the vestibulo- 
ocular reflex (VOR) using optically reversed vision (left-right prisms) during head rotations in the horizontal plane. 
It was of no surprise that most subjects experienced motion sickness while wearing the optically reversing prisms. 
However, a serendipitous finding emerged during this research showing that the same subjects did not experience 
motion sickness symptoms when wearing the reversing prisms under stroboscopic illumination. The mechanism, by 
which this side-effect was believed to have occurred, is not clearly understood. However, the fact that no motion 
sickness was ever noted, suggests the possibility of producing finctionally usefil adaptation during space flight 
without the penalty of disabling motion sickness by controlling the rate of the adaptive process by means of an 
appropriate stroboscopically presented environment. 
After several recent meetings with Professor Melvill Jones, we were encouraged to repeat the motion sickness 
portions of his and Mandl’s 1981 stroboscopic experiment. In conducting this experiment we used a randomized 
cross-over design where subjects were randomly assigned to either a stroboscopic flash or no strobe for their first 
exposure in the experimental design. Twenty subjects (19 subjects completed the study) read a short passage from 
Treasure Island mounted on the wall approximately 1 m from their eyes while wearing left-right reversing prisms. 
The strobe on time of 3 p e c  and flash fiequency of 4 Hz was set to equal that used in the original study. Motion 
sickness was scored using a modified Miller and Graybiel scale that we constructed to include symptoms that may 
be elicited under conditions where reversing prisms are worn. On this scale a score of 5 represented Malaise IIa 
(mild motion sickness) and a score of 8 or above is approaching frank sickness. Symptoms were tracked and 
recorded every 5 min during the task. Testing was limited to 30 min unless the subject had reached the MIIa score, 
at which time the test was terminated Performance under stroboscopic illumination was significantly better than 
when the subjects read under normal room illumination while wearing the left-right reversing prisms. Based on 
these results we developed a goggle system using LCD material that can be “strobed”. To evaluate the effectiveness 
of stroboscopic goggles we tested an additional 9 subjects in addition to retesting 10 used in the stroboscopic pilot 
study described above. These 19 subjects wore a pair of “strobing” LCD goggles that could be cycled at 4 Hz. These 
subjects wore the goggles while also wearing left-right reversing prisms. Results while wearing the goggles showed 
that none of the 19 subjects scored at the MIIa level on the motion sickness rating scale. When the goggles did not 
flash (no strobe), 1 1 of the 19 developed symptoms above the MIIa criteria. 
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As a countermeasure the goggles seem to be effective, even with an on time of 10 msec (time the goggles are clear). 
We have also collected anecdotal data, fiom our personnel in the Neuroscience Laboratory at the Johnson Space 
Center, suggesting that the goggles may effective in preventing carsickness. 
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